News | Radiopharm Theranostics

ASX Releases

August 24, 2023

TerThera Terbium-161 isotope supply agreement expanded

Read more Read more

August 18, 2023

EGM Presentation

Read more Read more

August 18, 2023

EGM Results

Read more Read more

July 24, 2023

Dr Sherin Al-Safadi Appointed as Vice President Medical and Corporate Affairs

Read more Read more

June 13, 2023

Pivalate Educational Webinar 14 June 2023

Read more Read more

May 29, 2023

FDA Pre-IND Meeting Supports an IND Application for RAD101

Read more Read more

MEDIA releases

September 15, 2023

RAD Announces Clinical Data Presentation for 68Ga-Trivehexin (RAD 301), at 2023 EANM Annual Meeting

Read more Read more

July 27, 2023

RAD Announces F18-Pivalate Brain Glioma Imaging Study Published in Prestigious Peer Reviewed Journal

Read more Read more

May 2, 2023

Positive new publication for RAD301 platform

Read more Read more

February 21, 2023

FNN Interview with CEO about RAD's ambition to list on Nasdaq

Read more Read more

February 16, 2023

Investor Webinar

Read more Read more

February 14, 2023

RAD CEO interview with Proactive Investors and announcement of Nasdaq listing initiation

Read more Read more

Events and Presentations

July 31, 2023

Company Presentation July 2023

Read more Read more

Sign up to our mailing list.

Receive all the latest news from Radiopharm Theranostics.